Definitive Contract HR001112C0103

This is a firm-fixed-price delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services, to Bachem Americas Inc., a foreign-owned, for-profit pharmaceutical manufacturer. The contract has a ceiling value of $26,400.00 and an ultimate completion date of March 31, 2027. It is for the provision of extended stability studies of parathyroid hormone-related protein (PTH-IA) to support...

Takara Bio Inc. was awarded a $5,200 purchase order by the National Institutes of Health (NIH) to deliver GMP grade CH-296 with certificate of analysis totaling 2.5 milligrams. The product will be delivered to Fabio Candotti at NIH's Bethesda, Maryland campus by May 30, 2009. As a small business set-aside, this firm fixed price contract supports NIH's ongoing biomedical research efforts through the targeted procurement of specialized compounds from commercial suppliers. No subcontractors were...

This is a $4,797,261 definitive contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Ginkgo Bioworks, Inc., a biotechnology company based in Boston. The contract is for DARPA's "SUPERB: SYNBIO + UNIVERSAL PURIFICATION OF EXTRACT-DERIVED, RIGHT-ON-TIME BIOLOGICS" program, which aims to develop technologies enabling immediate synthesis of bioactive protein medical countermeasures and production enzymes within 24 hours at a yield of at least 500 doses per week....

This contract was awarded by the Department of the Army Acquisition Support Center Joint PEO Chemical and Biological Defense to Immunome, Inc., a self-certified small disadvantaged business, for a COVID-19 Scalable Biosynthetic Convalescent Plasma (IMM-BCP-001) project. The contract is an Other Transaction Agreement with a potential value of $17,598,597.00 and a completion date of July 31, 2023. The contract does not have a set-aside designation. The purpose of this contract is to deliver...

This firm fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Synbio Technologies LLC, a small business located in Monmouth Junction, New Jersey. The $11,994.20 contract is for the delivery of a synthetic plasmid containing the AP50c phage genome, modified to include an eGFP tag. The requirement was originally posted as a special notice by the U.S. Army Medical Research Acquisition Activity (USAMRAA) on behalf of the U.S. Army Medical Research Institute of Infectious...

The Department of Health and Human Services Centers for Disease Control and Prevention awarded Promab Biotechnologies, Inc. a $16,630.00 firm fixed-price purchase order for antibody production services. This contract had a small business set-aside designation and was performed in Richmond, California, with a completion date of August 6, 2021. Promab Biotechnologies is a minority-owned, Asian-Pacific American-owned, for-profit small business that develops and commercializes recombinant...

This is a firm fixed-price purchase order contract awarded by the Joint PEO Chemical and Biological Defense, a defense agency, to Research Corp Technologies Inc. for the renewal of a Pichia license. The purpose is to provide the vendor with access to proprietary cell bank information and derivative data for use in the development of a botulinum toxin vaccine. The contract has a ceiling value of $45,000.00 and a performance period ending on January 30, 2027. This contract does not have a...

This is a definitive cost-plus-fixed-fee contract awarded by the U.S. Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (ASPR) to Basilea Pharmaceutica International Ltd, a biopharmaceutical company based in Switzerland. The $85,175,444 contract supports the clinical development of BAL30072, a novel monosulfactam antibiotic for treating infections caused by multidrug-resistant gram-negative bacterial pathogens. This contract is not set aside...

This federal contract award to Genscript USA Inc., a biotechnology company in Piscataway, New Jersey, is for gene synthesis, expression, and purification services valued at $11,211.10. The contract was awarded by the U.S. Department of Agriculture's (USDA) Agricultural Research Service (ARS) and does not have a set-aside designation. The contract supports the production of recombinant mouse monoclonal IgE antibodies that can recognize and distinguish between nut allergens Ana o 3 and Car i 1....

This is a $756,418,674.67 definitive contract awarded by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response to Regeneron Pharmaceuticals Inc. The contract is for pharmaceutical and drug products, as well as large-scale production of therapeutics to support national emergency preparedness, such as the COVID-19 pandemic response. The contract does not have a set-aside designation. Regeneron has received other high-value contracts from...